Benzinga | Feb 24, 2021 07:06AM EST

NeoGenomics Q4 Adj. EPS $0.14 Beats $0.06 Estimate, Sales $126.00M Beat $123.48M Estimate

NeoGenomics (NASDAQ:NEO) reported quarterly earnings of $0.14 per share which beat the analyst consensus estimate of $0.06 by 133.33 percent. This is a 40 percent increase over earnings of $0.10 per share from the same period last year. The company reported quarterly sales of $126.00 million which beat the analyst consensus estimate of $123.48 million by 2.04 percent. This is a 17.90 percent increase over sales of $106.87 million the same period last year.